Literature DB >> 28034602

Contribution of Secreted NADase and Streptolysin O to the Pathogenesis of Epidemic Serotype M1 Streptococcus pyogenes Infections.

Luchang Zhu1, Randall J Olsen1, Jessica D Lee2, Adeline R Porter3, Frank R DeLeo3, James M Musser4.   

Abstract

Streptococcus pyogenes secretes many toxins that facilitate human colonization, invasion, and dissemination. NADase (SPN) and streptolysin O (SLO) are two toxins that play important roles in pathogenesis. We previously showed that increased production of SPN and SLO in epidemic serotype M1 and M89 S. pyogenes strains is associated with rapid intercontinental spread and enhanced virulence. The biological functions of SPN and SLO have been extensively studied using eukaryotic cell lines, but the relative contribution of each of these two toxins to pathogenesis of epidemic M1 or M89 strains remains unexplored. Herein, using a genetically representative epidemic M1 strain and a panel of isogenic mutant derivative strains, we evaluated the relative contributions of SPN and SLO toxins to virulence in mouse models of necrotizing myositis, bacteremia, and skin and soft tissue infection. We found that isogenic mutants lacking SPN, SLO, and both toxins are equally impaired in ability to cause necrotizing myositis. In addition, mutants lacking either SPN or SLO are significantly attenuated in the bacteremia and soft tissue infection models, and the mutant strain lacking production of both toxins is further attenuated. The mutant strain lacking both SPN and SLO production is severely attenuated in ability to resist killing by human polymorphonuclear leukocytes. We conclude that both SPN and SLO contribute significantly to S. pyogenes pathogenesis in these virulence assays.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28034602      PMCID: PMC5397666          DOI: 10.1016/j.ajpath.2016.11.003

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  [Purification and crystallization of NAD glycohydrolase of C streptococci].

Authors:  F J Fehrenbach
Journal:  Eur J Biochem       Date:  1971-01-01

2.  Identity of streptolysin-O and NAD-glycohydrolase (EC 3.2.2.5).

Authors:  F J Fehrenbach
Journal:  Z Naturforsch B       Date:  1971-12       Impact factor: 1.047

3.  Autonomous expression of the slo gene of the bicistronic nga-slo operon of Streptococcus pyogenes.

Authors:  Dragutin J Savic; William M McShan; Joseph J Ferretti
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  A molecular trigger for intercontinental epidemics of group A Streptococcus.

Authors:  Luchang Zhu; Randall J Olsen; Waleed Nasser; Stephen B Beres; Jaana Vuopio; Karl G Kristinsson; Magnus Gottfredsson; Adeline R Porter; Frank R DeLeo; James M Musser
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

Review 5.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

Review 6.  A novel endogenous inhibitor of the secreted streptococcal NAD-glycohydrolase.

Authors:  Michael A Meehl; Jerome S Pinkner; Patricia J Anderson; Scott J Hultgren; Michael G Caparon
Journal:  PLoS Pathog       Date:  2005-12-02       Impact factor: 6.823

7.  Transcriptome Remodeling Contributes to Epidemic Disease Caused by the Human Pathogen Streptococcus pyogenes.

Authors:  Stephen B Beres; Priyanka Kachroo; Waleed Nasser; Randall J Olsen; Luchang Zhu; Anthony R Flores; Ivan de la Riva; Jesus Paez-Mayorga; Francisco E Jimenez; Concepcion Cantu; Jaana Vuopio; Jari Jalava; Karl G Kristinsson; Magnus Gottfredsson; Jukka Corander; Nahuel Fittipaldi; Maria Chiara Di Luca; Dezemona Petrelli; Luca A Vitali; Annessa Raiford; Leslie Jenkins; James M Musser
Journal:  mBio       Date:  2016-05-31       Impact factor: 7.867

8.  Streptolysin O and its co-toxin NAD-glycohydrolase protect group A Streptococcus from Xenophagic killing.

Authors:  Maghnus O'Seaghdha; Michael R Wessels
Journal:  PLoS Pathog       Date:  2013-06-06       Impact factor: 6.823

9.  Diphosphopyridine nucleotidase as an extracellular product of streptococcal growth and its possible relationship to leukotoxicity.

Authors:  A W BERNHEIMER; P D LAZARIDES; A T WILSON
Journal:  J Exp Med       Date:  1957-07-01       Impact factor: 14.307

10.  Selective inhibition by preparations of streptococcal filtrates of the oxidative metabolism of mitochondria procured from rabbit myocardium.

Authors:  A W BERNHEIMER; A S CARLSON; A KELLNER
Journal:  J Exp Med       Date:  1956-10-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Listeriolysin O: A phagosome-specific cytolysin revisited.

Authors:  Brittney N Nguyen; Bret N Peterson; Daniel A Portnoy
Journal:  Cell Microbiol       Date:  2019-01-15       Impact factor: 3.715

2.  Polymorphisms in Regulator of Cov Contribute to the Molecular Pathogenesis of Serotype M28 Group A Streptococcus.

Authors:  Paul E Bernard; Priyanka Kachroo; Jesus M Eraso; Luchang Zhu; Jessica E Madry; Sarah E Linson; Matthew Ojeda Saavedra; Concepcion Cantu; James M Musser; Randall J Olsen
Journal:  Am J Pathol       Date:  2019-07-29       Impact factor: 4.307

3.  Streptolysin O Induces the Ubiquitination and Degradation of Pro-IL-1β.

Authors:  Dóra Hancz; Elsa Westerlund; Christine Valfridsson; Getachew Melkamu Aemero; Benedicte Bastiat-Sempe; Pontus Orning; Egil Lien; Michael R Wessels; Jenny J Persson
Journal:  J Innate Immun       Date:  2019-03-19       Impact factor: 7.349

4.  A Single Amino Acid Replacement in Penicillin-Binding Protein 2X in Streptococcus pyogenes Significantly Increases Fitness on Subtherapeutic Benzylpenicillin Treatment in a Mouse Model of Necrotizing Myositis.

Authors:  Randall J Olsen; Luchang Zhu; James M Musser
Journal:  Am J Pathol       Date:  2020-05-11       Impact factor: 4.307

5.  RocA Has Serotype-Specific Gene Regulatory and Pathogenesis Activities in Serotype M28 Group A Streptococcus.

Authors:  Paul E Bernard; Priyanka Kachroo; Luchang Zhu; Stephen B Beres; Jesus M Eraso; Zaid Kajani; S Wesley Long; James M Musser; Randall J Olsen
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

6.  Streptococcus pyogenes infects human endometrium by limiting the innate immune response.

Authors:  Antonin Weckel; Thomas Guilbert; Clara Lambert; Céline Plainvert; François Goffinet; Claire Poyart; Céline Méhats; Agnès Fouet
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

7.  MOLECULAR MECHANISMS CONTRIBUTING TO FUZZY EPIDEMICS CAUSED BY GROUP A STREPTOCOCCUS, A FLESH-EATING HUMAN BACTERIAL PATHOGEN.

Authors:  James M Musser
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

8.  Genome-Wide Screens Identify Group A Streptococcus Surface Proteins Promoting Female Genital Tract Colonization and Virulence.

Authors:  Luchang Zhu; Randall J Olsen; Stephen B Beres; Matthew Ojeda Saavedra; Samantha L Kubiak; Concepcion C Cantu; Leslie Jenkins; Prasanti Yerramilli; Layne Pruitt; Amelia R L Charbonneau; Andrew S Waller; James M Musser
Journal:  Am J Pathol       Date:  2020-03-19       Impact factor: 4.307

9.  Single Amino Acid Replacements in RocA Disrupt Protein-Protein Interactions To Alter the Molecular Pathogenesis of Group A Streptococcus.

Authors:  Paul E Bernard; Amey Duarte; Mikhail Bogdanov; James M Musser; Randall J Olsen
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

10.  Gene fitness landscape of group A streptococcus during necrotizing myositis.

Authors:  Luchang Zhu; Randall J Olsen; Stephen B Beres; Jesus M Eraso; Matthew Ojeda Saavedra; Samantha L Kubiak; Concepcion C Cantu; Leslie Jenkins; Amelia R L Charbonneau; Andrew S Waller; James M Musser
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.